Company Profile (AI Text)
Name: Amnion Life LLC
Canonical URL: https://wefunder.com/amnion.life
Updated at: 2026-07-25T05:01:01Z

Tagline: Amniobed, a Ground-Breaking Medical Device to Save Preterm Infants Lives
Elevator pitch: Nearly 15M infants worldwide are born premature. Due to underdeveloped organs, the dramatic shift from amniotic fluid to air puts them at risk for hypothermia, dehydration, and infections which can lead to sepsis, organ injuries, and even death. To substantially improve preterm infants' chances of survival and reduce the time needed in intensive care, we designed AmnioBed, a patented, cost-efficient, fluid-filled solution that can mimics a mother's amniotic fluid environment.

Key claims:
- Total raised on Wefunder: 474883 | citation: https://wefunder.com/amnion.life#claim-total-raised
- Total investors: 415 | citation: https://wefunder.com/amnion.life#claim-total-investors

Verified facts:
- Total raised on Wefunder: 474883 | observed_at: 2026-07-25T05:01:01Z | expires_at: 2026-07-26T05:01:01Z
- Total investors: 415 | observed_at: 2026-07-25T05:01:01Z | expires_at: 2026-07-26T05:01:01Z

Computed metrics:
- total_amount_raised: 474883
- total_investors: 415
- team_size: 4
- featured_investor_count: 1
- faq_count: 5
- recent_post_count: 0

Quick facts:
- In Amniobed, the preterm infant is partially submerged in synthetic amniotic fluid. | citation: https://wefunder.com/amnion.life#claim-fact-1
- Amniobed is intended to prevent hypothermia in preterm infants and decrease environmental heat loss. | citation: https://wefunder.com/amnion.life#claim-fact-2
- Hypothermia leads to poor medical outcomes and an increased chance of infant death. | citation: https://wefunder.com/amnion.life#claim-fact-3
- Strong patent portfolio with multiple patents in the US, China, and Japan and pending in Europe. | citation: https://wefunder.com/amnion.life#claim-fact-4
- Studies have shown 40% of infants admitted to the NICU from L&D are hypothermic in 1st hour of life. | citation: https://wefunder.com/amnion.life#claim-fact-5
- Significant calorie loss in the NICU leads to diminished weight gain and longer hospital stays | citation: https://wefunder.com/amnion.life#claim-fact-6
- 3 Years of R&D. Designed, sourced, procured, and assembled Amniobed Golden Hour plus software. | citation: https://wefunder.com/amnion.life#claim-fact-7
- The project was placed on pause in 2020 due to COVID-19. Raising capital to finish the prototype. | citation: https://wefunder.com/amnion.life#claim-fact-8

FAQ:
- Q: I know the life of infants in NiCU. This is a great innovation ,Would there be a chance of bringing minimum to $100 or $200.
  A: Yes. Thank you for your suggestion. I will lower the minimum investment so its more accessible to all investors. We have requested the change to Wefunder and they will be lowering the limit in the next few days.
- Q: This is great for savings precious lives indeed. Will Amnion Life make money from the one-time sale of each incubator or will incubators be leased for multi-year revenue and other products like filters increase revenue also?
  A: Our revenue model is based on a combination of capital equipment sales and consumables. There is an initial purchase or lease of the device by the hospital. It then requires daily, weekly and quarterly accessories and consumables such as amniotic fluid cartridges which are used daily, sterile infant cover and harness which are changed every 24-72 hours, infant monitoring accessories specially designed for the fluid environment of the incubator such as infant skin temperature sensors, O2 monit...
- Q: The terms state a 10% discount but the SAFE agreement that I received has a 0% discount (because the discount rate is 100%). Can you clarify?
  A: Hi Carl. Thank you for your support and investment. The SAFE agreement has discount of 10% which applies only if the next round for Amnion is funded at less than the cap value of $22.5/$25 million. If the next round is funded at greater than the cap value, the SAFE investors will receive the shares at $22.5/$25million valuation and discount will no longer apply. For example, if the next round closes at $40 million, the SAFE investors will receive their shares at the cap rate of $22.5/$25milli...
- Q: Very interesting idea, but I have a lot of questions that I hope you can address: 1. How much money do you need to get this through FDA approval in 2020? $1 million through crowdfunding won't get you there. 2. Why did you decide to go this route instead of VC? 3. What was the ...
  A: Hi Nico, These are great questions which I am sure other investors may also have. Please see below: 1) 1. How much money do you need to get this through FDA approval in 2020? $1 million through crowdfunding won't get you there. $1 million via crowdfund is the maximum allowed by SEC to be raised by companies via Regulation CF. This is only part of capital needed in order to get this through the FDA. The remainder of investment capital will come from institutional investors with $500K minimum i...
- Q: I'd like to know the current price per share before I invest.
  A: Hi Fernando, The equity purchased is in the form of SAFE agreement for future equity. The price per share for the current Wefunder SAFE investors will be determined upon close of the next round by institutional investors. Based on our projections and numbers, milestones achieved and our potential market, we believe we will be valued above $25 million. If we do get valued in the $25-$50million range, the current investors will be rewarded by having their shares purchased at the cap of $25milli...